| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer | Interim CFO
1 company
Ragosa Mark is a Chief Financial Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 36,722 | $45.92 | $1,686,157.82 | -46.1% | - | - | |
| Jan 8, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sell | 12,000 | $41.89 | $502,680.00 | -38.6% | +12.7% | - | |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 42,841 | $41.49 | $1,777,473.09 | -58.0% | +12.6% | - | |
| Nov 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 19,900 | $40.94 | $814,706.00 | -39.0% | +10.2% | - | |
| Oct 28, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 100 | $41.00 | $4,100.00 | -0.3% | +9.6% | - | |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 18,889 | $32.89 | $621,259.21 | -41.2% | +13.7% | - | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 18,299 | $28.80 | $527,011.20 | -40.4% | +17.8% | - | |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 88,395 | $26.56 | $2,347,335.10 | -52.2% | +8.4% | +99.2% | |
| Mar 20, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 15,944 | $23.11 | $368,465.84 | -40.5% | +17.3% | +93.5% | |
| Mar 19, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Financial Officer | Sale+OE | 20,343 | $23.10 | $469,923.30 | -30.3% | +21.1% | +97.7% |